Tag Archives: Navitoclax

Similar terminal half lives associated with Vismodegib Olaparib Navitoclax

In keeping with our earlier observations¬† trastuzumab was found to remain an ineffective inhibitor with ligandinduced ErbB3 and Vismodegib AKT phosphorylation following 1 hour and 24 hour procedure in both cell facial lines tested (data not shown). MM-111 is a … Continue reading

Posted in inhibitors | Tagged , , | Leave a comment